|
||
Narayana Health Initiates Phase II Clinical Trial of CAR-T | ||
Bengaluru, Karnataka, India
Narayana Health, one of the leading healthcare chain in India, today announced that they have offered support to Immuneel Therapeutics, to build the most advanced CAR-T cell laboratory at the Narayana Health city Bengaluru. With this Narayana Health will offer hospital-based CAR-T cell generating laboratory and initiate the Phase II Clinical Trial.
Dr. Sharat Damodar, Dr. Emmanuel Rupert, Dr. Devi Prasad Shetty, Dr. Sunil Bhat and Mrs. Sadaf Khan, mother of 2.6 year old Pakistani child along with children who have been treated using BMT
Addressing the gathering, Dr. Devi Shetty, Chairman and Founder, Narayana Health said, “In 2004 when we started our first unit in Bangalore with 2 members, our idea was to provide Bone Marrow Transplant facilities to the residents in and around Karnataka. I am glad and proud that today we have 25 doctors and 300 nursing expert team treating more than 25 -30patients every month and have become the sought-after chain for the treatment modality.”
“Approximately 2 lakh patients in India get diagnosed every year with various blood disorders, however, there are only few large scale BMT facilities calling for further capacity expansion. We are looking at adding 20 beds and setting up 4 more centres across Ahmedabad, Raipur, Mysore and Gurugram,” added Dr. Emmanuel Rupert, Managing Director and Group CEO, Narayana Health.
BMT is an effective treatment modality for cancerous conditions like acute and chronic Myeloid and Lymphoblastic Leukemia, Hodgkin’s and Non-hodgkin’s Lymphoma, Myeloproliferative Neoplasms, Primary Myelofibrosis and Multiple Myeloma. It is also the suggested form of treatment for blood disorders namely Aplastic Anaemia, Immunodeficiency disorders, congenital storage disorders, congenital errors of metabolism and Haemoglobinopathies such as Thalassemia and Sickle Cell Anaemia.
Elaborating about the potential of BMT, Dr. Sharat Damodar, Chairman - Oncology Services & Oncology Collegium, Clinical Director - MSMC, Sr. Consultant & Head of Adult Haematology & Bone Marrow Transplant Unit, Narayana Health City, said, “Though Bone Marrow Transplant has the potential to cure more than 20 types of diseases and success rate of around 70-80%, awareness about this treatment modality is poor both among patients as well as physicians requiring a holistic approach to educate them, so that this treatment can provide the benefits to more and more patients in our country.’’
“Another key challenge impacting the adoption of this modality is the lack of general awareness in the public and also the medical fraternity. While there has been advances and stem cells of unrelated donors and haploidentical (half matched) donors have been used for those lacking full matched family donors, there is still a mismatch. In a country of over 1.4 billion population, there are only approximately 5 lakh registered donor available while the number of patients been diagnosed with conditions that require BMT is growing, calling for greater awareness and access to facilities,” added Dr. Sunil Bhat, Vice Chairman - Oncology Services & Oncology Collegium, Director & Clinical Lead - Paediatric Haematology, Oncology, Blood and Bone Marrow Transplantation.
A memoir by Manas, a BMT survivor, was also unveiled during the event. The memoir captures his journey though the condition and treatment. The occasion also witnessed more than 100BMT recipients being felicitated for their fighting spirit.
About Narayana Health
For more details, Please visit www.narayanahealth.org. |
||
|
||||||||||||||||
| ||||||||||||||||